This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Bayer Aktiengesellschaft. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Steffen Gressies and His Patent on SOS1 Inhibitors.
Introduction
Steffen Gressies is an inventor associated with Berlin, Germany, and Bayer Aktiengesellschaft. His work includes a patent application concerning phosphorus derivatives designed as SOS1 inhibitors.
Latest Patents
Gressies is credited with 1 patent: “Phosphorus Derivatives as SOS1 Inhibitors.” The invention covers phosphorus derivatives, methods for preparing them, useful intermediate compounds, and pharmaceutical compositions and combinations containing them. It also describes using these compounds to manufacture treatments or preventive medicines for diseases, particularly hyperproliferative disorders associated with SOS1. The compounds may be used alone or alongside other active ingredients.
Career Highlights
Gressies’s listed patent work is connected with Bayer Aktiengesellschaft, a company active in pharmaceutical research and development. The patent describes a range of chemical compounds and potential therapeutic applications.
Collaborations
Felix Pape and Timo Stellfeld are identified as Gressies’s coworkers. Their names are associated with the professional context provided for his patent work.
Conclusion
Steffen Gressies’s patent on phosphorus derivatives as SOS1 inhibitors reflects research into potential pharmaceutical approaches for hyperproliferative disorders and related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
